GH directly inhibits steatosis and liver injury in a sex-dependent and IGF1-independent manner

A reduction in hepatocyte growth hormone (GH)-signaling promotes non-alcoholic fatty liver disease (NAFLD). However, debate remains as to the relative contribution of the direct effects of GH on hepatocyte function versus indirect effects, via alterations in insulin-like growth factor 1 (IGF1). To i...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Endocrinol
Autors principals: Sarmento-Cabral, Andre, del Rio-Moreno, Mercedes, Vazquez-Borrego, Mari C., Mahmood, Mariyah, Gutierrez-Casado, Elena, Pelke, Natalie, Guzman, Grace, Subbaiah, Papasani V., Cordoba-Chacon, Jose, Yakar, Shoshana, Kineman, Rhonda D.
Format: Artigo
Idioma:Inglês
Publicat: 2021
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7785648/
https://ncbi.nlm.nih.gov/pubmed/33112796
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1530/JOE-20-0326
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars